JP2024523429A5 - - Google Patents
Info
- Publication number
- JP2024523429A5 JP2024523429A5 JP2023578116A JP2023578116A JP2024523429A5 JP 2024523429 A5 JP2024523429 A5 JP 2024523429A5 JP 2023578116 A JP2023578116 A JP 2023578116A JP 2023578116 A JP2023578116 A JP 2023578116A JP 2024523429 A5 JP2024523429 A5 JP 2024523429A5
- Authority
- JP
- Japan
- Prior art keywords
- composition according
- virus
- viral infection
- alkyl
- neurological complications
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP21180462.0 | 2021-06-18 | ||
| EP21180462 | 2021-06-18 | ||
| PCT/EP2022/066548 WO2022263624A1 (en) | 2021-06-18 | 2022-06-17 | Novel compounds for the treatment and prevention of neurological complications of viral infections |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024523429A JP2024523429A (ja) | 2024-06-28 |
| JP2024523429A5 true JP2024523429A5 (cg-RX-API-DMAC7.html) | 2025-06-23 |
Family
ID=76532115
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023578116A Pending JP2024523429A (ja) | 2021-06-18 | 2022-06-17 | ウイルス感染の神経学的合併症の処置と予防のための新規化合物 |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US20240307339A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP4355316A1 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2024523429A (cg-RX-API-DMAC7.html) |
| KR (1) | KR20240022560A (cg-RX-API-DMAC7.html) |
| CN (1) | CN117529311A (cg-RX-API-DMAC7.html) |
| WO (1) | WO2022263624A1 (cg-RX-API-DMAC7.html) |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4150125A (en) * | 1977-09-30 | 1979-04-17 | Abbott Laboratories | Triglyceride ester of phosphonoacetic acid having antiviral activity |
| JP2000007581A (ja) * | 1998-06-18 | 2000-01-11 | Nippon Kayaku Co Ltd | 抗ウイルススプレー剤 |
| KR20120129898A (ko) * | 2009-12-30 | 2012-11-28 | 베일러 리서치 인스티튜트 | 알츠하이머 질환 및 노화 뇌를 위한 보충대사 치료요법 |
| CN104940589A (zh) * | 2015-06-18 | 2015-09-30 | 王峰 | 治疗急性结膜炎的中药制剂及制法 |
| NZ749389A (en) * | 2016-06-08 | 2022-12-23 | Sunregen Healthcare Ag | Lipids with odd number of carbon atoms and their use as pharmaceutical composition or nutritional supplement |
| WO2018159941A1 (ko) * | 2017-03-02 | 2018-09-07 | 대화제약 주식회사 | 자나미비르를 포함하는 안정한 약제학적 조성물 |
| KR101991661B1 (ko) * | 2017-03-02 | 2019-06-21 | 대화제약 주식회사 | 자나미비르를 포함하는 안정한 약제학적 조성물 |
| WO2019052629A1 (en) * | 2017-09-12 | 2019-03-21 | Sunregen Healthcare Ag | LIPIDS HAVING AN IMPERATIVE NUMBER OF CARBON ATOMS AND THEIR USE AS A PHARMACEUTICAL COMPOSITION OR FOOD SUPPLEMENT |
-
2022
- 2022-06-17 JP JP2023578116A patent/JP2024523429A/ja active Pending
- 2022-06-17 KR KR1020247001041A patent/KR20240022560A/ko active Pending
- 2022-06-17 EP EP22734578.2A patent/EP4355316A1/en active Pending
- 2022-06-17 US US18/571,123 patent/US20240307339A1/en active Pending
- 2022-06-17 WO PCT/EP2022/066548 patent/WO2022263624A1/en not_active Ceased
- 2022-06-17 CN CN202280043349.6A patent/CN117529311A/zh active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| O’Brien et al. | Acyclovir: an updated review of its antiviral activity, pharmacokinetic properties and therapeutic efficacy | |
| Chou et al. | Ganciclovir ophthalmic gel 0.15% for the treatment of acute herpetic keratitis: background, effectiveness, tolerability, safety, and future applications | |
| De Clercq et al. | Therapeutic potential of nucleoside/nucleotide analogues against poxvirus infections | |
| D Vadlapudi et al. | Current and emerging antivirals for the treatment of cytomegalovirus (CMV) retinitis: an update on recent patents | |
| JP2021080269A5 (cg-RX-API-DMAC7.html) | ||
| JP6862366B2 (ja) | 眼のウイルス感染症の治療のための医薬品 | |
| Sekizawa et al. | Encephalitis resulting from reactivation of latent herpes simplex virus in mice | |
| JP2024520132A5 (cg-RX-API-DMAC7.html) | ||
| US9840525B2 (en) | Crystal form of tenofovir prodrug, preparation method thereof, and method of use thereof | |
| US12454540B2 (en) | Prodrugs of L-BHDU and methods of treating viral infections | |
| JP2002540146A5 (cg-RX-API-DMAC7.html) | ||
| JP2007530703A5 (cg-RX-API-DMAC7.html) | ||
| JP2015515496A5 (cg-RX-API-DMAC7.html) | ||
| CA2548608A1 (en) | Anhydrous crystalline form of valacyclovir hydrochloride | |
| US20030144235A1 (en) | 4'-thio-L-xylofuranosyl nucleosides, precursors thereof, preparation and use thereof | |
| WO2003101456A1 (de) | Verwendung von cgmp stimulierenden verbindungen | |
| KR960704464A (ko) | 포유동물 세포에서의 뉴클레오사이드와 뉴클레오베이스 수송억제 방법 및 바이러스 복제억제 방법(method for inhibiting nucleoside and nucleoside transport and virus replication in mammalian cells) | |
| Beadle et al. | Synthesis and antiviral evaluation of 1-O-hexadecylpropanediol-3-P-acyclovir: efficacy against HSV-1 infection in mice | |
| CN106794363A (zh) | 在单一丸剂/片剂/胶囊中米诺环素、氟康唑和阿托伐他汀在治疗多发性硬化中的用途 | |
| Higaki et al. | Effect of oral valaciclovir on herpetic keratitis | |
| US20140364407A1 (en) | Medical or therapeutic application of a composite material of ruthenium with a nitrosyl ligand | |
| Licastro | Exogenous and Endogenous Virus Infection and Pollutants Drive Neuronal Cell Senescence and Alzheimer's Disease. | |
| JP2024522820A5 (cg-RX-API-DMAC7.html) | ||
| Shiota | Clinical evaluation of acyclovir in the treatment of ulcerative herpetic keratitis | |
| JENSEN et al. | Acyclovir in the treatment of herpetic keratitis |